McClure Natalie
Insider CIK 1604572 · ADMS SVP, Product Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2016-04-18 | 2016-04-20 | 23,334 | — | $0 | 16,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2016-04-18 | 2016-04-20 | 12,666 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2016-04-18 | 2016-04-20 | 12,666 | $1.76 | $22.3K | 21,006 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2016-04-18 | 2016-04-20 | 23,334 | $0.67 | $15.6K | 31,674 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2016-04-18 | 2016-04-20 | 23,334 | $18.50 | $431.7K | 8,340 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2016-04-18 | 2016-04-20 | 12,666 | $18.50 | $234.3K | 8,340 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2016-03-04 | 2016-03-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2016-03-04 | 2016-03-08 | 7,500 | $13.66 | $102.5K | 8,340 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-06-05 | 2015-06-09 | 2,000 | — | $0 | 12,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-06-05 | 2015-06-09 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-06-05 | 2015-06-09 | 2,000 | $18.95 | $37.9K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-05-05 | 2015-05-07 | 2,000 | — | $0 | 14,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-05-05 | 2015-05-07 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-05-05 | 2015-05-07 | 2,000 | $17.62 | $35.2K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-04-06 | 2015-04-07 | 2,000 | — | $0 | 16,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-04-06 | 2015-04-07 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-04-06 | 2015-04-07 | 2,000 | $17.44 | $34.9K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-03-05 | 2015-03-09 | 2,000 | — | $0 | 18,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-03-05 | 2015-03-09 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-05 | 2015-03-09 | 2,000 | $17.15 | $34.3K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2015-02-25 | 2015-02-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-02-05 | 2015-02-06 | 2,000 | — | $0 | 20,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-02-05 | 2015-02-06 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-02-05 | 2015-02-06 | 2,000 | $16.87 | $33.7K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2015-01-05 | 2015-01-07 | 2,000 | — | $0 | 22,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2015-01-05 | 2015-01-07 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-01-05 | 2015-01-07 | 2,000 | $17.59 | $35.2K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2014-12-05 | 2014-12-09 | 2,000 | — | $0 | 24,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-12-05 | 2014-12-09 | 2,000 | $14.01 | $28.0K | 840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2014-12-05 | 2014-12-09 | 2,000 | $1.76 | $3.5K | 2,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise deriv | 2014-12-01 | 2014-12-03 | 20,000 | — | $0 | 26,666 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | M Exercise | 2014-12-01 | 2014-12-03 | 20,000 | $1.76 | $35.2K | 20,840 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-12-01 | 2014-12-03 | 20,000 | $14.50 | $290.0K | 840 | SEC↗ |